Patent details

EP3551626 Title: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Basic Information

Publication number:
EP3551626
PCT Application Number:
US2017033666
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP177283264
PCT Publication Number:
WO2018106284
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
French Title of Invention:
COMPOSÉS DE BENZÈNESULFONAMIDE ET LEUR UTILISATION EN TANT QU'AGENTS THÉRAPEUTIQUES
German Title of Invention:
BENZOLSULFONAMIDVERBINDUNGEN UND DEREN VERWENDUNG ALS ARZNEIMITTEL
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
27/10/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
02/11/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
25/10/2023
Unitary Effect Registration Date:
02/11/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
19/05/2017
Grant date:
25/10/2023
EP Publication Date:
16/10/2019
PCT Publication Date:
14/06/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2023
EP B1 Publication Date:
25/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2023
 
 

Name:
Xenon Pharmaceuticals Inc.
Address:
200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada (CA)

Inventor

1

Name:
FOCKEN, Thilo
Address:
Canada (CA)

2

Name:
BOGUCKI, David Earl
Address:
Canada (CA)

3

Name:
WILSON, Michael, Scott
Address:
Canada (CA)

4

Name:
ZENOVA, Alla, Yurevna
Address:
Canada (CA)

5

Name:
GRIMWOOD, Michael, Edward
Address:
Canada (CA)

6

Name:
ANDREZ, Jean-Christophe
Address:
Canada (CA)

7

Name:
CHOWDHURY, Sultan
Address:
Canada (CA)

8

Name:
DEVITA, Robert, Joseph
Address:
Canada (CA)

9

Name:
COHEN, Charles, Jay
Address:
Canada (CA)

10

Name:
DEHNHARDT, Christoph, Martin
Address:
Canada (CA)

11

Name:
DECKER, Shannon, Marie
Address:
Canada (CA)

12

Name:
HASAN, Syed, Abid
Address:
Canada (CA)

13

Name:
BURFORD, Kristen, Nicole
Address:
Canada (CA)

14

Name:
EMPFIELD, James, Roy
Address:
Canada (CA)

15

Name:
JOHNSON, James, Philip, Jr.
Address:
Canada (CA)

16

Name:
JIA, Qi
Address:
Canada (CA)

Priority

Priority Number:
201662432169 P
Priority Date:
09/12/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07D 403/12; C07D 213/76; C07D 237/20; C07D 239/69; C07D 413/12; C07D 261/16; C07D 493/10; C07D 277/52; C07D 285/08; A61K 31/426; A61P 25/08; C07D 417/12;

Publication

European Patent Bulletin

1

Issue number:
202343
Publication date:
25/10/2023
Description:
Grant (B1)

2

Issue number:
202349
Publication date:
06/12/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202349
Publication date:
06/12/2023
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages